These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 6056370)
21. The judgment of quality. Tice LF Am J Pharm Sci Support Public Health; 1970; 142(6):223-4. PubMed ID: 5527811 [No Abstract] [Full Text] [Related]
22. Quality drugs and the Saskatchewan formulary. Johnson GE Can J Hosp Pharm; 1975; 28(3):84-6. PubMed ID: 10316621 [No Abstract] [Full Text] [Related]
23. WHO Expert Committee on specifications for pharmaceutical preparations. World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445 [TBL] [Abstract][Full Text] [Related]
24. The quality control and stability testing of homeopathic preparations. Marotta M; Addabbo I; Kosasi S Boll Chim Farm; 1998 Nov; 137(10):439-41. PubMed ID: 9880948 [TBL] [Abstract][Full Text] [Related]
25. Rationale drug therapy: reasons for failure and suggestions for its implementation. Mathur GP; Kushwaha KP; Mathur S Indian Pediatr; 1993 Jun; 30(6):815-8. PubMed ID: 7726879 [No Abstract] [Full Text] [Related]
26. Securing the US pharmaceutical supply. Somberg JC Am J Ther; 2008; 15(3):197. PubMed ID: 18496255 [No Abstract] [Full Text] [Related]
27. Assuring the quality of the nation's drugs. Interview by William E. Small. Michels D Am Pharm; 1980 Apr; NS20(4):40-2. PubMed ID: 7386377 [No Abstract] [Full Text] [Related]
28. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-first report. World Health Organization World Health Organ Tech Rep Ser; 2007; (943):1-156. PubMed ID: 17621973 [TBL] [Abstract][Full Text] [Related]
30. Report on the PQRI impurity characterization and quantification best practices survey. Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396 [No Abstract] [Full Text] [Related]
31. National drug quality assurance system. Wijesekera T Ceylon Med J; 1993 Jun; 38(2):58-60. PubMed ID: 8370088 [No Abstract] [Full Text] [Related]
32. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573 [TBL] [Abstract][Full Text] [Related]
33. Expired drugs are not dead drugs. Torigian PC Am J Hosp Pharm; 1993 Mar; 50(3):448. PubMed ID: 8442459 [No Abstract] [Full Text] [Related]
34. ASHP technical assistance bulletin on quality assurance for pharmacy-prepared sterile products. Am J Hosp Pharm; 1993 Nov; 50(11):2386-98. PubMed ID: 8266973 [No Abstract] [Full Text] [Related]
35. WHO expert committee on specifications for pharmaceutical preparations. World Health Organ Tech Rep Ser; 1984; 704():1-54. PubMed ID: 6437087 [No Abstract] [Full Text] [Related]
36. Ingredients in pharmaceutical preparations: a problem not value. Lubner GC Boll Chim Farm; 2002; 141(5):332. PubMed ID: 12481372 [No Abstract] [Full Text] [Related]
37. [Official inspections of a pharmaceutical plant during the registration of new products]. De Martiis F; Fontani F; Zanotti-Gerosa A Boll Chim Farm; 1982 Jul; 121(7):319-27. PubMed ID: 7150440 [No Abstract] [Full Text] [Related]
38. Drug product quality as viewed by quality assurance personnel. Benney TL J Am Pharm Assoc; 1976 Nov; 16(11):601-2. PubMed ID: 977884 [No Abstract] [Full Text] [Related]
39. Toward more effective drug regulation. Schmidt AM FDA Consum; 1975 Dec-1976 Jan; 9(10):27-9. PubMed ID: 10316532 [No Abstract] [Full Text] [Related]
40. Regulatory agencies, manufacturers and scientists in assurance of quality drugs. Higuchi T Med Serv J Can; 1967 Mar; 23(3):381-6. PubMed ID: 6056381 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]